Status:
COMPLETED
Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria
Lead Sponsor:
Organon and Co
Conditions:
Rhinitis
Urticaria
Eligibility:
All Genders
12+ years
Brief Summary
Eligible patients will be prescribed Desloratadine 1 tablet of 5 mg once daily. Patients will be asked to follow-up for a final visit after 14 days (Day 15) where the safety, tolerability and clinical...
Eligibility Criteria
Inclusion
- Outpatient men or women, age 12 years and above.
- Diagnosis of Allergic Rhinitis or Chronic Idiopathic Urticaria
Exclusion
- Known hypersensitivity to Desloratadine.
- Pregnancy or lactation
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
3011 Patients enrolled
Trial Details
Trial ID
NCT00724698
Start Date
October 1 2005
End Date
December 1 2007
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.